Publication

Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Brenda W. Gillespie, University of MichiganHal Morgenstern, University of MichiganElizabeth Hedgeman, EpidStat InstituteAnca Tilea, University of MichiganNatalie Scholz, University of MichiganTempie Shearon, University of MichiganNilka Rios Burrows, Centers for Disease Control and PreventionVahakn B. Shahinian, University of MichiganJerry Yee, Henry Ford Health SystemLaura Plantinga, Emory UniversityNeil R. Powe, University of California, San FranciscoWilliam McClellan, Emory UniversityBruce Robinson, Arbor Research Collaborative for HealthDesmond E. Williams, Centers for Disease Control and PreventionRajiv Saran, University of Michigan
Language
  • English
Date
  • 2015-12
Publisher
  • Oxford University Press (OUP): Policy C - Option B
Publication Version
Copyright Statement
  • © The Author 2015.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2048-8505
Volume
  • 8
Issue
  • 6
Start Page
  • 772
End Page
  • 780
Grant/Funding Information
  • Support for this work was also provided under a cooperative agreement from the Centers for Disease Control and Prevention (CDC) through grant numbers 5U36CD319276 and 5U58DP003836-04.
  • This study was supported through grants from the Centers for Medicare & Medicaid Services, CMS contract numbers HHSM-500-2006-00042C and HHSM-500-2011-00091C.
Abstract
  • Background: Longer nephrology care before end-stage renal disease (ESRD) has been linked with better outcomes. Methods: We investigated whether longer pre-end-stage renal disease (ESRD) nephrology care was associated with lower mortality at both the patient and state levels among 443 761 incident ESRD patients identified in the USA between 2006 and 2010. Results: Overall, 33% of new ESRD patients had received no prior nephrology care, while 28% had received care for >12 months. At the patient level, predictors of >12 months of nephrology care included having health insurance, white race, younger age, diabetes, hypertension and US region. Longer pre-ESRD nephrology care was associated with lower first-year mortality (adjusted hazard ratio = 0.58 for >12 months versus no care; 95% confidence interval 0.57–0.59), higher albumin and hemoglobin, choice of peritoneal dialysis and native fistula and discussion of transplantation options. Living in a state with a 10% higher proportion of patients receiving >12 months of pre-ESRD care was associated with a 9.3% lower relative mortality rate, standardized for case mix (R2 = 0.47; P < 0.001). Conclusions: This study represents the largest cohort of incident ESRD patients to date. Although we did not follow patients before ESRD onset, our findings, both at the individual patient and state levels, reflect the importance of early nephrology care among those with chronic kidney disease.
Author Notes
Keywords
Research Categories
  • Health Sciences, Epidemiology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items